2011
DOI: 10.1016/j.bcp.2010.10.006
|View full text |Cite
|
Sign up to set email alerts
|

Acetaminophen-induced stimulation of MDR1 expression and activity in rat intestine and in LS 174T human intestinal cell line

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
24
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 21 publications
(26 citation statements)
references
References 29 publications
2
24
0
Order By: Relevance
“…Therefore, compounds influencing those transporters may also affect the formation of BG and BS. For instance, APAP was shown to induce intestinal MDR1 expression in rat intestine (Ghanem et al, 2011). EC itself and its sulfates were demonstrated to be substrates of the efflux transporter MRP2 in C-2C monolayer model (Vaidyanathan and Walle, 2001).…”
Section: Ratio Of Total Metabolites Formed Vs Total Parentmentioning
confidence: 98%
“…Therefore, compounds influencing those transporters may also affect the formation of BG and BS. For instance, APAP was shown to induce intestinal MDR1 expression in rat intestine (Ghanem et al, 2011). EC itself and its sulfates were demonstrated to be substrates of the efflux transporter MRP2 in C-2C monolayer model (Vaidyanathan and Walle, 2001).…”
Section: Ratio Of Total Metabolites Formed Vs Total Parentmentioning
confidence: 98%
“…The change in pharmacokinetics and therapeutic efficacy of these drugs, may be clinically relevant [49]. In addition, in human livers, altered MDR expression has been described in APAP consumption toxicity [50] .…”
Section: Discussionmentioning
confidence: 99%
“…We conclude that APAP pretreatment significantly (p<0.05) increases MDR1 activity, and that the efflux of APAP (parent drug) and/or its metabolites was accelerated. Ghanem et al report that APAP can induce MDR1 expression and activity in rat intestines and in the LS 174T human intestinal cell line [49]. …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We have demonstrated that the administration of repeated subtoxic, intraperitoneal doses of AP (0.2, 0.3, and 0.6 g/kg, injected in 3 consecutive days) to rats upregulated the expression and activity of P‐gp in intestine. This induction altered the pharmacokinetics of digoxin, a prototypical P‐gp substrate, decreasing its bioavailability when administered intraluminally . It has been noted that many substrates of P‐gp are also inducers of the transporter .…”
Section: Introductionmentioning
confidence: 99%